A Landscape Review of Multispecific Therapies

• Highlighting the preclinical and clinical landscape, with an emphasis on mechanisms and target combinations
• Analyzing the commercial landscape, focusing on leading companies and key deals
• Examining the future of the bispecific field

Speakers:

Longli Zhou

Senior Lead Research Analyst - Beacon Bispecific

Beacon Intelligence